Skip to content

Clinical trials

Cardiomyopathies trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Country / region: Sweden Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20122
20142
20151
20182
20192
20204
20231
20241
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting5
Active, not recruiting2
Unknown status2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals5
Bayer2
Intellia Therapeutics2
Karolinska University Hospital2
Sahlgrenska University Hospital2
Celladon Corporation1
Eidos Therapeutics, a BridgeBio company1
Ionis Pharmaceuticals, Inc.1
Linkoeping University1
Region Skane1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies20
Amyloidosis8
Heart Diseases4
Amyloid Neuropathies, Familial3
Amyloidosis, Familial3
Heart Failure3
Alzheimer Disease2
Cardiovascular Diseases2
Polyneuropathies2
Shock, Septic2

Trials

Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.